Markets:

Overview

News

Currencies

International

Treasuries

SeaStar Medical Holding Corporation - Common Stock (NQ:ICU)

3.530 -0.110 (-3.02%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about SeaStar Medical Holding Corporation - Common Stock

< Previous 1 2 3 Next >

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

March 13, 2026

From Virtual Investor Conferences

Via GlobeNewswire

Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th

March 10, 2026

Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th

March 09, 2026

The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at...

From Virtual Investor Conferences

Via GlobeNewswire

SeaStar Medical's QUELIMMUNE Wins Prestigious Award From The National Kidney Foundation, Former Winners Include Names Like Janssen, Merck and Otsuka

July 11, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

SeaStar Medical's QUELIMMUNE Wins Prestigious Award From The National Kidney Foundation, Former Winners Include Names Like Janssen, Merck and Otsuka

July 11, 2025

Via TheNewswire.com

SeaStar's QUELIMMUNE Can Cut Pediatric Sepsis Deaths In Half

June 27, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Death

SeaStar's QUELIMMUNE Can Cut Pediatric Sepsis Deaths In Half

June 27, 2025

Via TheNewswire.com

Topics Death

EXECUTIVE INTERVIEW: SeaStar CMO And Pediatric Specialist Talk About Promising Therapy To Treat Pediatric AKI

June 27, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

EXECUTIVE INTERVIEW: SeaStar CMO And Pediatric Specialist Talk About Promising Therapy To Treat Pediatric AKI

June 27, 2025

Via TheNewswire.com

SeaStar Q1 Results: QUELIMMUNE Sales Up Fourfold Sequentially, Company Now Targeting Adult Market

May 29, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Earnings

SeaStar Q1 Results: QUELIMMUNE Sales Up Fourfold Sequentially, Company Now Targeting Adult Market

May 29, 2025

Via TheNewswire.com

Topics Earnings

How SeaStar Medical Is Leveraging Its Breakthrough Medical Device Designation To Help Critically Ill Patients

May 21, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

How SeaStar Medical Is Leveraging Its Breakthrough Medical Device Designation To Help Critically Ill Patients

May 21, 2025

Via TheNewswire.com

How SeaStar Medical Joined Select Ranks Of Medical Device Innovators With Six FDA Breakthrough Device Designations

May 13, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

How SeaStar Medical Joined Select Ranks Of Medical Device Innovators With Six FDA Breakthrough Device Designations

May 13, 2025

Via TheNewswire.com

SeaStar's QUELIMMUNE Therapy For Pediatric AKI Adopted By Hospitals In Multiple States, Adult Treatment In Pipeline

May 12, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

SeaStar's QUELIMMUNE Therapy For Pediatric AKI Adopted By Hospitals In Multiple States, Adult Treatment In Pipeline

May 12, 2025

Via TheNewswire.com

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

March 24, 2025

From SeaStar Medical

Via GlobeNewswire

SEASTAR ALERT: Bragar Eagel & Squire, P.C. is Investigating SeaStar Medical Holding Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

December 16, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Eric Schlorff, CEO of SeaStar Medical Holding Corporation (NASDAQ: ICU), to Present at NobleCon20

November 14, 2024

Via Investor Brand Network

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against SeaStar Medical Holding Corporation (ICU)

September 05, 2024

From The Law Offices of Frank R. Cruz

Via Business Wire

ICU Deadline: Rosen Law Firm Urges SeaStar Medical Holding Corporation (ICU, ICUCW) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

September 05, 2024

From Rosen Law Firm

Via Business Wire

ICU Investors Have Opportunity to Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit with the Schall Law Firm

September 03, 2024

From Schall Law

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm

August 30, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

ICU DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important September 6 Deadline in Securities Class Action – ICU

August 30, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SeaStar

August 29, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm

August 26, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SeaStar

August 22, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ICU

August 22, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, FutureFuel, SeaStar, and Bolt and Encourages Investors to Contact the Firm

August 20, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.